Correlation Between Medicofarma Biotech and New Tech

Can any of the company-specific risk be diversified away by investing in both Medicofarma Biotech and New Tech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicofarma Biotech and New Tech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medicofarma Biotech SA and New Tech Venture, you can compare the effects of market volatilities on Medicofarma Biotech and New Tech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicofarma Biotech with a short position of New Tech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicofarma Biotech and New Tech.

Diversification Opportunities for Medicofarma Biotech and New Tech

0.41

Correlation Coefficient

Medicofarma Biotech  New Tech

Very weak diversification

The 3 months correlation between Medicofarma and New is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Medicofarma Biotech SA and New Tech Venture in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on New Tech Venture and Medicofarma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicofarma Biotech SA are associated (or correlated) with New Tech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of New Tech Venture has no effect on the direction of Medicofarma Biotech i.e., Medicofarma Biotech and New Tech go up and down completely randomly.

Pair Corralation between Medicofarma Biotech and New Tech

Assuming the 90 days trading horizon Medicofarma Biotech SA is expected to under-perform the New Tech. In addition to that, Medicofarma Biotech is 1.32 times more volatile than New Tech Venture. It trades about -0.12 of its total potential returns per unit of risk. New Tech Venture is currently generating about -0.14 per unit of volatility. If you would invest  16.00  in New Tech Venture on August 30, 2024 and sell it today you would lose (3.00) from holding New Tech Venture or give up 18.75% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	64.52%
Values	Daily Returns

Medicofarma Biotech SA  vs.  New Tech Venture

Medicofarma Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medicofarma Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

New Tech Venture

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days New Tech Venture has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Medicofarma Biotech and New Tech

The main advantage of trading using opposite Medicofarma Biotech and New Tech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicofarma Biotech position performs unexpectedly, New Tech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in New Tech will offset losses from the drop in New Tech's long position.

The idea behind Medicofarma Biotech SA and New Tech Venture pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..